Showing results (1-10 of 209) with videos related to
Sort By:
Pageof 21
Nature Clinical Practice. Cardiovascular Medicine|March 28, 2008
Aortic regurgitation: disease progression and managementSeth H Goldbarg, Jonathan L HalperinProgress in Cardiovascular Diseases|July 19, 2008
Sudden cardiac death in infiltrative cardiomyopathies: sarcoidosis, scleroderma, amyloidosis, hemachromatosisSteven A Lubitz, Seth H Goldbarg, Davendra MehtaIndian Heart Journal|January 8, 2009
Stroke prevention in atrial fibrillation--pharmacologic strategiesSatish R Tiyyagura, Seth H Goldbarg, Davendra MehtaJournal of the American College of Cardiology|September 25, 2007
Insights into degenerative aortic valve diseaseSeth H Goldbarg, Sammy Elmariah, Marc A Miller, et al.Thrombosis Research|October 3, 2002
Evaluation of patients with peripheral vascular diseaseJonathan L HalperinExpert Review of Cardiovascular Therapy|May 21, 2004
Antithrombotic therapy in atrial fibrillation: ximelagatran, an oral direct thrombin inhibitorJonathan L HalperinJournal of Cardiovascular Medicine (Hagerstown, Md.)|June 26, 2009
What can ongoing clinical trials of anticoagulants demonstrate?Jonathan L HalperinJournal of the American College of Cardiology|January 5, 2005
Ximelagatran: oral direct thrombin inhibition as anticoagulant therapy in atrial fibrillationJonathan L HalperinThe American Journal of Geriatric Cardiology|March 24, 2005
Anticoagulation for atrial fibrillation in the elderlyJonathan L HalperinPageof 21